Cargando…
Application of Angiotensin Receptor–Neprilysin Inhibitor in Chronic Kidney Disease Patients: Chinese Expert Consensus
Chronic kidney disease (CKD) is a global public health problem, and cardiovascular disease is the most common cause of death in patients with CKD. The incidence and prevalence of cardiovascular events during the early stages of CKD increases significantly with a decline in renal function. More than...
Autores principales: | Gan, Liangying, Lyu, Xiaoxi, Yang, Xiangdong, Zhao, Zhanzheng, Tang, Ying, Chen, Yuanhan, Yao, Ying, Hong, Fuyuan, Xu, Zhonghao, Chen, Jihong, Gu, Leyi, Mao, Huijuan, Liu, Ying, Sun, Jing, Zhou, Zhu, Du, Xuanyi, Jiang, Hong, Li, Yong, Sun, Ningling, Liang, Xinling, Zuo, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343998/ https://www.ncbi.nlm.nih.gov/pubmed/35928297 http://dx.doi.org/10.3389/fmed.2022.877237 |
Ejemplares similares
-
Angiotensin receptor-neprilysin inhibition in patients with acute decompensated heart failure: an expert consensus position paper
por: Ntalianis, Argyrios, et al.
Publicado: (2021) -
Angiotensin receptor blocker neprilysin inhibitors
por: Usuda, Daisuke, et al.
Publicado: (2021) -
Effect of angiotensin receptor neprilysin inhibitors on left atrial remodeling and prognosis in heart failure
por: Sun, Yuxi, et al.
Publicado: (2021) -
Angiotensin receptor-neprilysin inhibitors and cardiac remodeling
por: Ryazanov, A.S., et al.
Publicado: (2023) -
Safety of the neprilysin/renin-angiotensin system inhibitor LCZ696
por: Li, Bo, et al.
Publicado: (2017)